Combined short-term hepatitis B immunoglobulin (HBIG) and long-term lamivudine (LAM) versus HBIG monotherapy as hepatitis B virus (HBV) prophylaxis in liver transplant recipients

被引：0
|
作者：
Terrault, NA
Wright, TL
Roberts, JP
Ascher, NL
机构：
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[3] VAMC, San Francisco, CA USA
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
905
引用
收藏
页码：389A / 389A
页数：1
相关论文
共 50 条
  • [31] Renal Function Difference Between Anti-Hepatitis B Immunoglobulin(HBIG) Monotherapy and HBIG Combined with Entecavir
    Lee, Jae Geun
    Lee, Juhan
    Lee, Jung Jun
    Song, Seung Hwan
    Lee, Jee Youn
    Kim, Su-Kyung
    Ju, Man Ki
    Kim, Myoung Soo
    Choi, Gi Hong
    Choi, Jin Sub
    Kim, Soon Il
    Joo, Dong Jin
    TRANSPLANTATION, 2016, 100 : S136 - S137
  • [32] Long-term persistence of hepatitis B virus (HBV) in liver transplanted patients under anti-HBS immunoglobulins (HBIG).
    Virot, V
    Samuel, D
    Feray, C
    Gigou, M
    Roche, B
    Arulnaden, JL
    Bismuth, H
    HEPATOLOGY, 1996, 24 (04) : 1167 - 1167
  • [33] A long-term follow-up of combination HBIG end lamivudine in preventing recurrent hepatitis B in 61 orthotopic liver transplant (OLT) recipients.
    Han, SH
    Holt, C
    Martin, P
    Drazan, K
    Artinian, L
    Kunder, G
    Farmer, D
    Ghobrial, R
    Busuttil, RW
    TRANSPLANTATION, 1999, 67 (09) : S586 - S586
  • [34] Lamivudine use for recurrent hepatitis B post liver transplant following failure of HBIG prophylaxis.
    Minford, EJ
    Smith, B
    Bawa, S
    Talbot, D
    Manas, D
    Thick, M
    Mirza, D
    HEPATOLOGY, 1997, 26 (04) : 1737 - 1737
  • [35] Renal Function Difference Between Anti-Hepatitis B Immunoglobulin(HBIG) Monotherapy and HBIG Combined With Entecavir
    Lee, Jae Geun
    Lee, Juhan
    Lee, Jung Jun
    Kim, Myoung Soo
    Ju, Man Ki
    Choi, Gi Hong
    Choi, Jin Sub
    Kim, Soon Il
    Joo, Dong Jin
    TRANSPLANTATION, 2015, 99 : 210 - 210
  • [36] RENAL FUNCTION DIFFERENCE BETWEEN ANTI-HEPATITIS B IMMUNOGLOBULIN (HBIG) MONOTHERAPY AND HBIG COMBINED WITH ENTECAVIR
    Lee, Jae Geun
    Ju, Man Ki
    Choi, Sub Jin
    Kim, Soon Il
    Kim, Myoung Soo
    Joo, Dong Jin
    Lee, Juhan
    Song, Seung Hwan
    TRANSPLANT INTERNATIONAL, 2015, 28 : 707 - 707
  • [37] Human B immunoglobuline (HBIG) monotherapy or combined with lamivudine (LAM) in prophylaxis of HBV recurrence after liver transplantation (LT) in HBsAg-carriers
    Gaia, S
    Marzano, A
    Ciardo, V
    Gentilcore, E
    Lagget, M
    Smedile, A
    Rizzetto, M
    JOURNAL OF HEPATOLOGY, 2002, 36 : 37 - 37
  • [38] Combination HBIG and lamivudine is both highly efficacious and cost-effective in preventing recurrent hepatitis B in orthotopic liver transplant recipients compared to HBIG monotherapy.
    Han, SHB
    Martin, P
    Ofman, J
    Holt, C
    Drazan, K
    Artinian, L
    Kunder, G
    Farmer, D
    Ghobrial, RM
    Busuttil, RW
    HEPATOLOGY, 1999, 30 (04) : 242A - 242A
  • [39] Is lamivudine with 1-week HBIg as effective as long-term high-dose HBIg in HBV prophylaxis after liver transplantation?
    Park, SJ
    Paik, SW
    Choi, MS
    Lee, JH
    Koh, KC
    Kim, SJ
    Joh, JW
    Lee, SK
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (04) : 1252 - 1254
  • [40] Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis
    Beckebaum, Susanne
    Herzer, Kerstin
    Bauhofer, Artur
    Gelson, William
    De Simone, Paolo
    de Man, Robert
    Engelmann, Cornelius
    Muellhaupt, Beat
    Vionnet, Julien
    Salizzoni, Mauro
    Volpes, Riccardo
    Ercolani, Giorgio
    De Carlis, Luciano
    Angeli, Paolo
    Burra, Patrizia
    Dufour, Jean-Francois
    Rossi, Massimo
    Cillo, Umberto
    Neumann, Ulf
    Fischer, Lutz
    Niemann, Gabriele
    Toti, Luca
    Tisone, Giuseppe
    ANNALS OF TRANSPLANTATION, 2018, 23 : 789 - 801
12345